Abstract
Although hepatitis E virus (HEV) is regarded as a self-limiting infection and anti-HEV antibodies seem to protect against reinfection, its pathogenesis is not well established. We describe 2 cases of acute symptomatic HEV infection after hepatitis C therapy in patients carrying anti-HEV immunoglobulin G antibodies, raising 2 major questions: reactivation or reinfection?
Author supplied keywords
Cite
CITATION STYLE
Rivero-Juarez, A., Frias, M., Lopez-Lopez, P., De Los Angeles Risalde, M., Brieva, T., Machuca, I., … Rivero, A. (2017). Hepatitis e virus (HEV) infection in anti-HEV immunoglobulin g-carrying patients after successful hepatitis C virus treatment: Reactivation or reinfection? Clinical Infectious Diseases, 64(7), 964–966. https://doi.org/10.1093/cid/cix004
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
